Early data from the Bundibugyo Ebola outbreak in DRC suggest that around two-thirds of reported cases are women. Not because of biology, but because exposure is shaped by caregiving roles, healthcare work and community practices. Read more: https://nature.pulse.ly/hnyn2x5piy

Preparing for future pandemics starts before the next outbreak. At #GHS2026 in Kuala Lumpur, Diana Stepanyan showcased ERINHA & INTERCEPTOR's contribution to international cooperation in high-containment research. 🌍 #ERINHA #INTERCEPTOR #GlobalHealthSecurity #Preparedness #ResearchInfrastructure

New genomic data from Madagascar show that mpox clade Ib was likely introduced from mainland Africa before establishing local transmission. A reminder that genomic surveillance doesn't just confirm cases—it helps reconstruct how outbreaks emerge and spread. Read more: https://shorturl.at/8v0yl

🌍 Land-use change is often discussed as a biodiversity issue. It may also be a pandemic risk issue. A new study identifies hotspots where large-scale agricultural land conversion overlaps with conditions associated with zoonotic spillover risk. https://shorturl.at/tJ1y3

“One plan, one budget, one team.” WHO and Africa CDC have launched a joint continental response plan to tackle the largest recorded Bundibugyo Ebola outbreak and strengthen preparedness across the region. https://who.pulse.ly/brsn0gbx91

New CDC modeling highlights how quickly the ongoing Bundibugyo Ebola outbreak could grow without strong interventions. The key takeaway: rapid case detection & isolation can dramatically reduce epidemic size. A reminder that outbreak response is often a race against time https://shorturl.at/7UnlQ

New reporting on the Ebola outbreak response highlights how fragile global health coordination has become — at a time when international collaboration matters most. Preparedness depends on science, trust, and sustained cooperation. https://shorturl.at/V31bY #Ebola #GlobalHealth #ERINHA

The 2026 Ebola outbreak reveals how fragile global preparedness still is. Delayed detection, no vaccine for the Bundibugyo strain, fragmented coordination, & shrinking funding. Victor Dzau’s piece also captures a familiar cycle in global health: panic, neglect, repeat. https://shorturl.at/g2uz5

The Ebola outbreak in DRC is a reminder that emerging infectious diseases require preparedness, surveillance & international collaboration. Strengthening high-containment research capacities & One Health approaches remains essential. Read more: https://www.nature.com/articles/d41586-026-01645-y

From Ebola in DRC to hantavirus outbreaks linked to international travel, emerging infectious diseases continue to highlight the importance of global preparedness, surveillance, and coordinated response systems. https://shorturl.at/kgZ9q

Climate change is accelerating the emergence and spread of infectious diseases. This important report echoes the mission of projects such as #CCHFVACIM, #NAVIPP and #INTERCEPTOR in strengthening Europe’s readiness against emerging health threats. https://shorturl.at/PpWmk

🎉ERINHA is pleased to welcome the Biomedical Primate Research Centre @bprc-eu.bsky.social as new member! 🎯By joining forces, we continue to build a stronger European research ecosystem, reinforcing our commitment to pandemic preparedness & global health resilience. erinha.eu/news/strengt...

🚨 WHO has declared the Ebola outbreak caused by Bundibugyo virus in DRC and Uganda a Public Health Emergency of International Concern (PHEIC). At ERINHA, strengthening epidemic preparedness and global health security remains central to our mission. Read more: https://shorturl.at/BXCIj

ERINHA is proud to contribute to the Resilience Day – EU MCM Stakeholder Workshop at the 7th CBRNe International Conference in Arcachon 🇪🇺 A key discussion on Europe’s preparedness against CBRN threats. 📅 20 May 2026 🔗 https://cbrneconference.fr/resilience-day.html #CBRN #HealthSecurity

New evidence confirms the circulation of #mpox Clade Ib in Madagascar, highlighting the importance of genomic surveillance and regional cooperation across the Indian Ocean. At ERINHA, we support collaborative approaches to strengthen epidemic preparedness and response. https://shorturl.at/87o45

Lassa fever: no licensed vaccine yet—and a key gap remains. Identifying immune correlates of protection is critical to accelerate vaccine development and preparedness. ERINHA facilitates access to high-containment research infrastructure. https://www.nature.com/articles/s41541-026-01452-6

#Hantavirus cluster on a cruise ship (7 cases, 3 deaths) linked to travel in South America. Rare but severe zoonotic disease under investigation. WHO assesses global risk as low. #Hantavirus #GlobalHealth #Outbreak 🔗 Source https://www.who.int/emergencies/disease-outbreak-news/item/2026-DON599

Vaccines are powerful—but they don’t act alone. A new Nature Communications study shows how sleep can shape immune responses and vaccine effectiveness. Not a challenge to vaccines—just a reminder #CCHFVACIM | #NAVIPP | #INTERCEPTOR https://www.nature.com/articles/s41467-026-72212-2

A disease you rarely hear about is testing preparedness - again. Lassa fever is surging in Nigeria in 2026. Not new, not unexpected - yet the same gaps persist. Preparedness must be continuous, not reactive. #INTERCEPTOR project https://shorturl.at/V9KaJ

📢 Registration open: 2026 BSL4ZNet Virtual Conference Join global experts on high-containment labs, biosafety & emerging infectious diseases. Free & open to all (May–June 2026). 🔗 https://site.pheedloop.com/event/2026BSL4ZNet/register#category #BSL4 #Biosafety #GlobalHealth

🚀 ERINHA joins the Global Health EDCTP3 Stakeholders’ Group! We’re proud to contribute to shaping global health research priorities and strengthening international collaboration in the fight against infectious diseases. 🔗 https://shorturl.at/asUqi #GlobalHealth #EDCTP3 #ERINHA

🌍 INTERCEPTOR expands its global network with 5 new partners A stronger international collaboration to boost pandemic preparedness—connecting high-containment labs, expertise, and infrastructures worldwide. 🔗 Read more: https://shorturl.at/J9nbH #INTERCEPTOR #ERINHA

📢 The Open Letter is live! With #IGWG6 starting next week, every signature counts — add your voice and share 👇 🔗 https://www.dsiscientificnetwork.org/open-letter-2026/ #GlobalHealth #OpenScience #IGWG6

Big thank you to all ERINHA Members — long-standing and newly joined — for joining our Meeting in Paris 2 days of connecting, welcoming new members, & shaping our network’s future. Discussions highlighted shared ambition driving high-containment research & pandemic preparedness in Europe & beyond

Smiles, teamwork, and real progress 💪 Great to see the INTERCEPTOR community together in Paris for the annual meeting — proud of what’s been achieved so far! #INTERCEPTOR #TeamScience

🔬 Want to level up your virology skills? ERINHA member is organizing a Course in Virology at Erasmus MC (23–27 Nov 2026), bringing together top European experts. 🧬 Emerging viruses, immune response, clinical insights & more 💰 €100 | Limited seats 👉 Don’t miss it! #InfectiousDiseases #ERINHA

📢 New publication in PLOS Biology ERINHA is proud to have coordinated this perspective on strengthening international biosafety and biosecurity practices. Read it here: journals.plos.org/plosbiology/...

Attending the "International Symposium on Tick Borne Pathogens and Disease ITPD 2026"? https://www.itpd-tickborne.com/2026/programme.php Come and meet Iva Trifonova from Iva Cristova's team, our partner and WP leader in #CCHFVACIM project https://www.cchfvacim.eu/

We are recruiting a European Project Manager (Junior profile) to join ERINHA’s Central Coordinating Unit in Paris. 📍 Paris (hybrid) 📝 Apply by 3 April 2026 📅 Start: May 2026 Full details and how to apply: erinha.eu/news/vacancy...

25–26 Feb 2026, Rome: the RICH Europe Symposium highlights best practices in RI collaboration, interoperability & data sharing across @horizoneu.bsky.social Diana Stepanyan will present ISIDORe: how integrated RI services accelerate research on epidemic-prone pathogens. 🔗 shorturl.at/OrZJU

🚀 #CCHFVACIM is advancing an mRNA vaccine against CCHF toward Phase II trials — building on CCHFVaccine results. Progress relies on sustained BSL-3/4 access and strong European collaboration. 🔗 Read more: https://cchfvacim.pulse.ly/w0zkvexwgw

Science alone won’t stop Lassa fever 3 vaccine candidates are in development; one could be licensed within a decade. West African countries must prepare now: define priority groups, strengthen regulation, secure financing, plan delivery, and build trust https://project-syndicate.pulse.ly/xq1qpeyqci

🔬 From neglected disease to vaccine candidates. #CCHFVaccine advanced CCHF research w/ new models, secure sample pipelines & high-containment access 🧬 DNA & mRNA vaccines now lead the way — EU collaboration turning preparedness into solutions. https://europa.pulse.ly/n46d36bhj3 @ec.europa.eu

Mpox continues to circulate globally. 2025: 52,845 confirmed cases / 98 countries. New outbreak in Madagascar (Dec 2025), clade Ib, community transmission ongoing. Research infrastructures matter. #Mpox #ERINHA https://who.pulse.ly/b4qtsarahe

🦠 A little-known virus. A very real risk for Europe Crimean-Congo Haemorrhagic Fever (CCHF) is a deadly tick-borne disease (up to 40% fatality) with no licensed vaccine 🔗 Read on CORDIS:https://cordis.europa.eu/article/id/463154-preventive-action-against-deadly-tick-borne-disease #CCHFVACIM

🌍 Six years after COVID-19: are we better prepared for the next pandemic? https://who.pulse.ly/gfqruvz3lm ✅ Yes, because major progress has been made ⚠️ No, because these gains remain fragile and uneven #PandemicPreparedness #WHO #ERINHA #OneHealth #Solidarity #ResearchInfrastructures

🔍 Understanding emerging health risks through scientific expertise As new cases of Nipah virus have been reported in India, The Conversation has published an in-depth, well-contextualised analysis by Allen Cheng, Professor of Infectious Diseases. https://theconversation.pulse.ly/rska4mshba

WHO regrets the US notification of withdrawal, warning it weakens global health security. The organization defends its COVID-19 response, rejects claims of politicization, and reaffirms its impartial, evidence-based mandate:https://who.pulse.ly/eq04kv08zn

Intranasal, broad-spectrum, structurally validated: a new macrocyclic peptide shows strong protection against SARS-CoV-2 Omicron variants. 📄 https://www.nature.com/articles/s41467-026-68462-9

🔬 New in Nature Communications: evidence of silent #mpox exposure in healthy adults in Nigeria. 🧬 Combining serology + genomics, the study shows how residual smallpox immunity shapes transmission — and why integrated surveillance matters. 📄 https://doi.org/10.1038/s41467-026-68335-1

Ethiopia declares end of first-ever Marburg virus disease outbreak https://www.afro.who.int/countries/ethiopia/news/ethiopia-declares-end-first-ever-marburg-virus-disease-outbreak

#Marburg in Tanzania (outbreaks 2023 & 2025): genome sequencing shows the strains were near-identical (>99.71% identity). Likely local spillover + limited human-to-human spread → need stronger eco/behavioral studies + surveillance in the Great Lakes zone. https://cdc.pulse.ly/otayrzokqs

Rwanda’s #Marburg response cut fatality rates to ~23% through rapid surveillance, genomics & coordinated action. A clear case for sustained investment in preparedness and research infrastructures. Nature Medicine: https://www.nature.com/articles/s41591-025-04163-y

#Nipah virus remains a high-risk pandemic threat with up to 70% fatality and no licensed vaccine. A new Nature Health Comment highlights urgent needs for better diagnostics, standardized assays, and vaccine-ready models to strengthen global outbreak preparedness. https://nature.pulse.ly/7dktxy8mw4

The EU has allocated €1.2 million in emergency aid to support the response to the Marburg outbreak in southern Ethiopia, strengthening surveillance, patient care, contact tracing and community engagement through WHO, International Medical Corps and the Red Cross. https://europa.pulse.ly/n3mybebsgd

🧪 As a partner in #ISIDORe, #ERINHA contributes its expertise on high-risk pathogens and preparedness, supporting Europe’s capacity to respond to emerging infectious diseases. 👉 Read on CORDIS: https://shorturl.at/k1SyC #ResearchInfrastructures #InfectiousDiseases #EUProjects

Emerging infectious diseases New in Nature: the oral antiviral 4′-fluorouridine protected non-human primates from lethal Lassa fever when administered at an advanced stage of infection. Read more: https://www.nature.com/articles/s41586-025-09906-y #HighConsequencePathogens #AntiviralResearch

🦇 Hendra virus detected in a bat in Australia’s Northern Territory (first confirmed NT detection; test 11 Dec 2025). Authorities say risk remains unchanged, but surveillance & biosecurity matter to reduce spillover risk. https://daf.nt.gov.au/news/2025/first-nt-detection-of-hendra-virus-in-a-bat

🔬 In Bangladesh, 5 severe “Nipah-like” cases linked to raw date palm sap tested NiV-negative. Sequencing identified Pteropine orthoreovirus (PRV), highlighting the need for broad surveillance & differential diagnosis in spillover settings. https://wwwnc.cdc.gov/eid/article/31/12/25-0797_article#;

One Health Trial Design could speed up #Lassa vaccine trials by combining ecological surveillance + viral genomics + socio-behavioral monitoring → smarter site selection + better case accrual + stronger real-world effectiveness estimates. https://www.nature.com/articles/s41591-025-04018-6